tivantinib | Cafepharma

Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup

Submitted by admin on Thu, 05/11/2017 - 11:41

Source

Endpoints

Headline

Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup

News Tags

Daiichi, ArQule cancer drug fails in late-stage study

Submitted by admin on Sat, 02/18/2017 - 14:43

Source

BioPharma Dive

Headline

Daiichi, ArQule cancer drug fails in late-stage study

News Tags

clinical trials

Battered ArQule shares bump up on badly needed positive data for tivantinib

Submitted by admin on Mon, 11/10/2014 - 11:13

Source

Fierce Biotech

Headline

Battered ArQule shares bump up on badly needed positive data for tivantinib

News Tags

metastatic prostate cancer

ArQule shares rise after committee say liver cancer study can continue with lower drug dose

Submitted by admin on Fri, 01/17/2014 - 08:39

Source

Yahoo/AP

Headline

ArQule shares rise after committee say liver cancer study can continue with low…

News Tags

Data on ArQule's Tivantinib

Submitted by admin on Sat, 10/05/2013 - 09:18

Source

Yahoo/Zacks

Headline

Data on ArQule's Tivantinib

News Tags

non-small cell lung cancer

ArQule up on hope for lung cancer drug revival

Submitted by admin on Fri, 09/27/2013 - 11:51

Source

Reuters

Headline

ArQule up on hope for lung cancer drug revival

News Tags

ArQule to cut liver cancer drug dose on safety concerns

Submitted by admin on Tue, 09/03/2013 - 16:20

Source

Reuters

Headline

ArQule to cut liver cancer drug dose on safety concerns

News Tags

ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib

Submitted by admin on Thu, 01/31/2013 - 10:48

Source

Yahoo/Fly on the Wall

Headline

ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib

News Tags

hepatocellular carcinoma

Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance

Submitted by admin on Tue, 01/15/2013 - 11:39

Source

Seeking Alpha

Headline

Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance

News Tags

colorectal cancer

ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?

Submitted by admin on Fri, 10/12/2012 - 12:17

Source

Seeking Alpha

Headline

ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correl…

News Tags

non-small cell lung cancer

Subscribe to tivantinib